Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Preliminary Evidence of Increased Hippocampal Myelin Content in Veterans with Posttraumatic Stress Disorder.
Both endoplasmic reticulum and mitochondrial pathways are involved in oligodendrocyte apoptosis induced by capsular hemorrhage.
Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
Comparison of Antioxidant Status and Vitamin D Levels between Multiple Sclerosis Patients and Healthy Matched Subjects.
Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) regulatory T cells in multiple sclerosis.
Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.
Does Natalizumab Therapy Benefit Patients With Multiple Sclerosis?
Functional and structural cerebral changes in key brain regions after a facilitation programme for episodic future thought in relapsing-remitting multiple sclerosis patients.
The Neuroprotective Effect of the Association of Aquaporin-4/Glutamate Transporter-1 against Alzheimer's Disease.
Is electroconvulsive therapy safe in multiple sclerosis?
Physical therapy provision in multiple sclerosis across Europe: a regional lottery?
Guillain Barré Syndrome in a multiple myeloma patient after the first course of bortezomib therapy: A case report.
Pre-Existing Mature Oligodendrocytes Do Not Contribute to Remyelination following Toxin-Induced Spinal Cord Demyelination.
Syndrome of inappropriate antidiuretic hormone secretion in patients with aquaporin-4 antibody.
Alterations in Immune Cells and Mediators in the Brain: It's Not Always Neuroinflammation!
IL-17A activates ERK1/2 and enhances differentiation of oligodendrocyte progenitor cells.
Hippocampal function is compromised in an animal model of multiple sclerosis.
Work Participation and Executive Abilities in Patients with Relapsing-Remitting Multiple Sclerosis.
Attributions and self-efficacy for physical activity in multiple sclerosis.
Restriction genes for retroviruses influence the risk of multiple sclerosis.
Mortality following a brain tumour diagnosis in patients with multiple sclerosis.
Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications.
Pregnancy and multiple sclerosis: the children of PRIMS.
In vivo imaging of human neuroinflammation.
Antigen microarrays identify CNS-produced autoantibodies in RRMS.
Pages
« first
‹ previous
…
688
689
690
691
692
693
694
695
696
…
next ›
last »